Navigation Links
3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
Date:7/11/2011

SHENYANG, China, July 11, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the Chinese State Food and Drug Administration ("SFDA") has approved its 36,000 IU dosage formulation of EPIAO for the treatment of anemia associated with chemotherapy in cancer patients. High-dose EPIAO is the only dosage form of this kind available in China. The approval provides patients in China with an additional treatment option which has been available since 2004 in the United States and 2006 in the United Kingdom.

High-dose EPIAO is designed for the rapid restoration of hemoglobin to normal levels among cancer patients. The 36,000 IU dosage is comparable to the standardized dose used globally for chemotherapy-induced anemia, allowing for less frequent administration than lower dosage forms, which in turn is expected to provide greater convenience for both patients and caregivers.  

The clinical trial examined the safety and efficacy of a weekly subcutaneous injection of 36,000 IU EPIAO in oncology patients compared with a regimen of three times per week administration of 10,000 IU EPIAO. The results showed that 70% of the patients receiving high-dose EPIAO injections had hemoglobin improvement of 1-2 g/dL from baseline, similar to those receiving three times per week dosing of 10,000 IU EPIAO. More importantly, the weekly administration of 36,000 IU EPIAO demonstrated equivalent safety and tolerability profiles as the three times per week 10,000 IU EPIAO.

Commenting on the news, Dr. Jing Lou, chief executive officer of 3SBio, said: "Our new 36,000 IU formulation of EPIAO is the highest dose EPO formulation on the market in China, and EPIAO remains the only EPO product approved in
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. 3SBio Announces Conversion of Isotechnika Debenture
2. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
3. 3SBio Announces Partial Conversion of Isotechnika Debenture
4. 3SBio Announces Investor Conference Schedule
5. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
6. 3SBio Inc. Announces Results of Annual General Meeting
7. Surgical Care Affiliates Announces Agreement With Suburban Outpatient Surgery Center
8. Pinnaclife Announces Prenatal Nutrition Package and Mother Baby Skin Care Line
9. Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
10. Vycor Medical, Inc. Announces Alvaro Pascual-Leone, MD, PhD as Head of the Strategic Advisory Board of its NovaVision, Inc. Subsidiary
11. Patient Advocate Foundation Announces Significant Operational, Technology Enhancements to Co-Pay Relief (CPR) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Calif. , May 26, 2015  Amgen (NASDAQ: ... results from the Phase 3 OPTiM study in the ... . The data published in JCO , ... the American Society of Clinical Oncology (ASCO) in 2013 ... (DRR) in patients with unresected stage IIIB, IIIC or ...
(Date:5/26/2015)... --  Generational Equity , a leading mergers and acquisitions ... the acquisition of its client, Peaks & Plains ... , by Mi-Med Supply , headquartered in Vista, ... Peaks & Plains is the only dual ... nutritional, patient care, and housekeeping equipment to long-term care ...
(Date:5/26/2015)... 26, 2015 Clinicient Inc , ... announced the results of an industry survey of ... 759 therapists, practice owners and administrative staff completed ... need for technology and services that improve therapist ... findings, Clinicient published a free 12-page guide to ...
Breaking Medicine Technology:Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8Generational Equity Announces the Acquisition of Peaks & Plains Inc. by Mi-Med Supply 2Survey: Half of Physical Therapists Underbill For Their Services 2
... #4061DENVER, April 21 Scientists from the Barbara ... today at the American Association for Cancer Research,s ... a brighter future for children who suffer from ... http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )Yubin Ge, Ph.D., and Chengzhi Xie, Ph.D., ...
... and Arisyn Therapeutics jointly announced today the successful ... Health to support the development of novel small ... virus (HCV) infection. ImQuest scientists will investigate ... ATI-0810 (Formerly PG301029) and a series of related ...
Cached Medicine Technology:Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 2Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 3ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 2
(Date:5/26/2015)... Two addiction experts from ... Pei on a CNBC radio podcast for a ... on KCAA AM 1050, the podcast features Tim Salyer, ... therapist, as they discuss current statistics on drug and ... 23.5 million Americans. The program, titled “Addiction, Self-Hatred, Hope ...
(Date:5/26/2015)... May 26, 2015 Relias Learning ... for the health and human services market, announces expansion ... demand. After strong attendance and participation in 2014, they ... give their annual user conference an exciting new facelift. ... to come together and discuss best practices, share their ...
(Date:5/26/2015)... 2015 Synthetic cannabinoids attempt to ... article published by International Business Times ... Spice, and black mamba) causes unpredictable medical and ... substances make it nearly impossible for medical doctors ... the substance due to the frequency in which ...
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. Marine ... treatments. Cosmetic dentistry is becoming increasingly popular in today’s ... committed to providing you with the highest level of ... a smile of a lifetime … We work with ... change your life,” explains Dr. Martirosyan’s team. “Giving you ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
Breaking Medicine News(10 mins):Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3
... at the Stanford University School of Medicine have devised a ... virtually separate a whole-blood sample into its different cell types ... of those cell types. In a study to be ... scientists reported that they had successfully used the new technique ...
... that much harder to eliminate, scientists say , SUNDAY, March ... the AIDS virus in the blood to zero, but HIV ... their pills. Now, research is giving scientists new insight into ... powers of medicine. , In a new study, researchers ...
... ... residents in hypertension therapy and sleep disorders will receive international recognition at the American ... ... work of two St. Elizabeth Internal Medicine residents in hypertension therapy and sleep disorders ...
... ... certification. Their revolutionary line of quick couplings and plastic fittings are all designed, ... ... -- Kent Systems received their Made in the USA Brand certification. Their revolutionary ...
... ... the 2010 Cinco de Mayo Half Marathon and the 12th Annual “Reaching for the Cure” ... ... Research Foundation (PCRF) announced the official sponsors for the annual “Reaching for the Cure” ...
... Age ... specialist-expert and nutritionist counselor, Rod Stanley, to give patients 1:1 attention and superior fitness ... ... expert and age management medicine icon, is boosting patient motivational levels by adding his ...
Cached Medicine News:Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 3Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 4Health News:HIV Hides Out in Bone Marrow Cells 2Health News:St. Elizabeth Medical Residents to Present Research at International Meeting, 2Health News:Kent Systems Received Made in the USA Brand Certification 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 2Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 3
Built-in convexity means added security and skin protection for recessed, retracted and flush stomas...pre-cut openings. Security and confidence achieved by the internal No-Flowback Valves and soft d...
Inquire...
Inquire...
Inquire...
Medicine Products: